این سایت در حال حاضر پشتیبانی نمی شود و امکان دارد داده های نشریات بروز نباشند
صفحه اصلی
درباره پایگاه
فهرست سامانه ها
الزامات سامانه ها
فهرست سازمانی
تماس با ما
JCR 2016
جستجوی مقالات
پنجشنبه 30 بهمن 1404
International Journal of Pediatrics
، جلد ۵، شماره ۳، صفحات ۴۴۷۹-۴۴۸۸
عنوان فارسی
چکیده فارسی مقاله
کلیدواژههای فارسی مقاله
عنوان انگلیسی
Evaluation of Children with Complication of BCG Vaccination in North of Iran
چکیده انگلیسی مقاله
Background: Although the efficacy of Bacillus Calmette-Guerin (BCG) vaccine in the prevention of tuberculosis has been noted consistently, the use of BCG vaccine is not without risk. In this study we aimed to evaluate immunologically, children with complication of BCG vaccination in North of Iran.Materials and Methods: This case-control study began in 30 Jan 2013 and was completed in 2 Jul 2015. In case group 35 patients with moderate to severe complications of BCG vaccination for Tuberculosis (TB), have been enrolled.Thecontrol group included 35 patients with mild complication and patients had no complications due to BCG vaccine. Routine and specific tests for evaluation of immunological function were performed.Results: Out of total number of 35 patients in case group, 3(8.6%) patients had severe complication, also they diagnosed as BCG-osis; 32(91.42%) cases had moderate symptoms. In the control group 25 (71.4%) patients had mild complications and 10(28.57%) patients had no complications. The mean of IL-23 level in the two groups had significant difference (P= 0.027). There was a significant relationship about interleukin and interferon deficiency among patients with severe complications. Patients with mild to moderate complications of BCG vaccine were not associated with immunodeficiency. Patients with severe complications of BCG vaccine, were associated with Mendelian susceptibility to mycobacterial disease (MSMD) primary immunodeficiency (PID).Conclusion: Severe complications of BCG vaccine could be due to MSMD and it may be associated with immune deficiency in IL 12/23. BCG vaccination must be deferring in newborns in families with a history of death following presumed BCG or early death or recurrent infection, until suitable screening immunological tests exclude the PID.
کلیدواژههای انگلیسی مقاله
نویسندگان مقاله
محمد صادق رضایی | mohammad sadegh rezai
associate professor, infectious diseases research center with focus on nosocomial infection, mazandaran university of medical sciences, sari, iran.
سازمان اصلی تایید شده
: دانشگاه علوم پزشکی مازندران (Mazandaran university of medical sciences)
فاطمه آهنگرکانی | fatemeh ahangarkani
phd student in medical mycology, antimicrobial resistance research center, student research committee, mazandaran university of medical sciences, sari, iran
سازمان اصلی تایید شده
: دانشگاه علوم پزشکی مازندران (Mazandaran university of medical sciences)
رقیه صادقی | roghaye sadeghi
resident of pediatrics, infectious diseases research center with focus on nosocomial infection, mazandaran university of medical sciences, sari, iran.
سازمان اصلی تایید شده
: دانشگاه علوم پزشکی مازندران (Mazandaran university of medical sciences)
محمدرضا مهدوی | mohammad reza mahdavi
assistant professor, thalassemia research center, hemoglobinopathy institute, mazandaran university of medical sciences, sari, iran.
سازمان اصلی تایید شده
: دانشگاه علوم پزشکی مازندران (Mazandaran university of medical sciences)
نشانی اینترنتی
http://ijp.mums.ac.ir/article_8277.html
فایل مقاله
اشکال در دسترسی به فایل - ./files/site1/rds_journals/317/article-317-325541.pdf
کد مقاله (doi)
زبان مقاله منتشر شده
en
موضوعات مقاله منتشر شده
نوع مقاله منتشر شده
برگشت به:
صفحه اول پایگاه
|
نسخه مرتبط
|
نشریه مرتبط
|
فهرست نشریات